Anteris Technologies Global Corp. Common Stock (AVR) - Total Liabilities
Based on the latest financial reports, Anteris Technologies Global Corp. Common Stock (AVR) has total liabilities worth $16.31 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Anteris Technologies Global Corp. Common net asset momentum to track the company's year-over-year net asset growth rate.
Anteris Technologies Global Corp. Common Stock - Total Liabilities Trend (2020–2025)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's total liabilities have evolved over time, based on quarterly financial data.
Anteris Technologies Global Corp. Common Stock Competitors by Total Liabilities
The table below lists competitors of Anteris Technologies Global Corp. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Johns LYNG Group Ltd
AU:JLG
|
Australia | AU$524.22 Million |
|
Logwin AG
F:TGHN
|
Germany | €394.61 Million |
|
Sharda Cropchem Limited
NSE:SHARDACROP
|
India | Rs22.27 Billion |
|
Cromwell Property Group
AU:CMW
|
Australia | AU$887.80 Million |
|
Guizhou Chitianhua Co Ltd
SHG:600227
|
China | CN¥2.12 Billion |
|
Talant Optronics (Suzhou) Co. Ltd.
SHE:301045
|
China | CN¥298.09 Million |
|
Fujian Longma Envi Sanitation
SHG:603686
|
China | CN¥3.36 Billion |
|
SKF India Limited
NSE:SKFINDIA
|
India | Rs7.50 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down Anteris Technologies Global Corp. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AVR stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 20.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anteris Technologies Global Corp. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anteris Technologies Global Corp. Common Stock (2020–2025)
The table below shows the annual total liabilities of Anteris Technologies Global Corp. Common Stock from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $23.25 Million | +29.04% |
| 2024-12-31 | $18.02 Million | +54.93% |
| 2023-12-31 | $11.63 Million | +67.27% |
| 2022-12-31 | $6.95 Million | -36.27% |
| 2021-12-31 | $10.91 Million | +38.12% |
| 2020-12-31 | $7.90 Million | -- |
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT ant… Read more